Effect of sodium-glucose cotransporter-2 inhibitor (SGLT2-i) in patients with LVAD: a systematic review and meta-analysis

被引:0
|
作者
Hasabo, E. A. [1 ,2 ]
Isik, B. [3 ]
Elgadi, A. [4 ]
Eljack, M. M. F. [5 ]
Yacuob, M. S. [1 ,2 ]
Alzomor, H. [1 ,2 ]
Sawabi, R. [1 ,2 ]
Sultan, S. [6 ]
Caliskan, K. [7 ]
Soliman, O. [1 ,2 ]
机构
[1] Univ Galway, CORRIB Core Lab, Galway, Ireland
[2] Galway Univ Hosp, Galway, Ireland
[3] Univ Limerick, Limerick, Ireland
[4] Univ Khartoum, Fac Med, Khartoum, Sudan
[5] Univ Bakht Alruda, Fac Med, Ad Duwaym, Sudan
[6] Univ Coll Hosp, Western Vasc Inst, Galway, Ireland
[7] Erasmus MC, Rotterdam, Netherlands
关键词
D O I
10.1093/eurheartj/ehae666.3355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] THE IMPACT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS ON MAJOR ADVERSE CARDIOVASCULAR EVENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Nithianandan, Harrish
    Sivasekaran, Akksayan
    Sivasekaran, Ahimsan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 628 - 628
  • [42] Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for mortality in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
    Froehlich, H.
    Taeger, T.
    Atar, D.
    Agewall, S.
    Katus, H. A.
    Grundtvig, M.
    Cleland, J. G. F.
    Clark, Al
    Frankenstein, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 50 - 50
  • [43] Effect of sodium-glucose cotransporter 2 inhibitors on insulin resistance; a systematic review and meta-analysis
    Fakhrolmobasheri, Mohammad
    Abhari, Amir Parsa
    Manshaee, Behrad
    Heidarpour, Maryam
    Shafie, Davood
    Mohammadbeigi, Ehsan
    Mozafari, Amir Mohammad
    Mazaheri-Tehrani, Sadegh
    ACTA DIABETOLOGICA, 2023, 60 (02) : 191 - 202
  • [44] Impact of sodium-glucose cotransporter-2 inhibitors in patients with recent versus previous myocardial infarction: a systematic review and meta-analysis
    Scardini, Pedro Gabriel
    Katsuyama, Eric Shih
    Prata, Alonzo Armani
    Fernandes, Julia Marques
    Fukunaga, Christian Ken
    Neto, Wilson Falco
    Coan, Ana Carolina Covre
    de Andrade, Naieli Machado
    Silva, Abraao Santana
    Pinheiro, Rafael Petri
    Pereira, Luciana Gioli
    Furtado, Remo H. M.
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [45] Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Atrial Fibrillation Recurrence Post-Ablation: A Systematic Review and Meta-Analysis
    Nugooru, Sudeep
    Ginnaram, Shravya
    Janga, Chaitra
    Sevella, Prerana
    Muhammadzai, Hamza
    Shah, Shreeja
    Sabri, Muhammad
    Alhassani, Zaineb
    Lee, Tyler
    Watson, Robert
    CIRCULATION, 2024, 150
  • [46] Impact of sodium-glucose cotransporter-2 inhibitors on heart failure outcomes in cancer patients and survivors: a systematic review and meta-analysis
    Bhalraam, U.
    Veerni, Rathna B.
    Paddock, Sophie
    Meng, James
    Piepoli, Massimo
    Lopez-Fernandez, Teresa
    Tsampasian, Vasiliki
    Vassiliou, Vassilios S.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2025,
  • [47] Evaluating the Cardioprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis of Recent Studies
    Nugooru, Sudeep
    Sevella, Prerana
    Ginnaram, Shravya
    Rallabhandi, Sai Sri Harsha
    Janga, Chaitra
    Haddad, Enad
    Sudireddy, Kavya
    Qadir, Shayan
    Shah, Shreeja
    Watson, Robert
    CIRCULATION, 2024, 150
  • [48] Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor
    Koch, Richard A.
    Clark, Richard F.
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (05) : E590 - E591
  • [49] Sodium-glucose cotransporter-2 inhibitor prescribing practices
    Alcorn, Chris
    Subarajan, Prathayini
    Kesari, Aditya
    Lockhart, Marie
    Cottrell, Daryl
    Jordan, Kim
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1136 - 1139
  • [50] Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Type 1 Diabetes: A Systematic Review and Meta-analysis
    El Masri, Dana
    Jaber, Linda
    DIABETES, 2017, 66 : LB41 - LB41